Sign Up to like & get
recommendations!
0
Published in 2019 at "Investigational New Drugs"
DOI: 10.1007/s10637-018-0709-3
Abstract: SummaryProstate-specific antigen (PSA) has been widely used as the unique serum biomarker for the diagnosis of prostate cancer (PCa). When PSA is moderately increased (e.g., 4–10 ng/ml), it is difficult to differentiate benign prostatic hyperplasia (BPH)…
read more here.
Keywords:
prostate;
prostate cancer;
cancer;
bph ... See more keywords